ArticleAmerican journal of cancer research2023
Transcriptomics data mining to uncover signature genes in head and neck squamous cell carcinoma: a bioinformatics analysis and RNA-sequencing based validation.
Article in American journal of cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 4 citations in OpenAlex.
- KIF23 in disease pathogenesis and therapeutics : from molecular mechanisms to clinical translation.Cancer cell international · 2026Review
- Unveiling the proteomic landscape: Exploring differentially expressed proteins in patients with jaw cysts.Medicine · 2026Article
- The Oncogenic Role of Long Non-Coding RNABiology · 2026Review
- A signature of correlated CDC20 and UBCH10 expression indicates poor prognosis in primary head and neck squamous cell carcinoma.BMC cancer · 2025Article
- The midbody and midbody remnant: from cellular debris to signaling organelle with diagnostic and therapeutic potential.Molecular biology of the cell · 2025Review
- Identification of ETV4 as a prognostic biomarker and correlates with immune cell infiltration in head and neck squamous cell carcinoma.Scientific reports · 2025Article
- Comprehensive analysis of the Cullin family of genes reveals that CUL7 and CUL9 are the significant prognostic biomarkers in colorectal cancer.American journal of translational research · 2024Article
- Multi-Omics Analysis and Experimental Validation Identify RAD51 as a Key Biomarker in OSCC.IET systems biologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to its heterogeneous nature, head and neck squamous cell carcinoma (HNSC) had the worst prognosis. Hence, there is an urgent need to develop novel diagnostic and prognostic models for effective disease management. A multi-layer dry-lab and wet-lab methodologies were adopted in the present study to identify novel diagnostic and prognostic biomarkers of HNSC. Initially, the GSE6631 gene microarray HNSC dataset was retrieved from the Gene Expression Omnibus (GEO) database. The R language-based "limma" package was employed to identify differentially expressed genes (DEGs) between HNSC and control samples. The Cytohubba plug-in software was used to identify the top four hub genes based on the degree score method. The Cancer Genome Atlas (TCGA) datasets, Gene Expression Omnibus (GEO) datasets, clinical HNSC tissue samples, HNSC cell line (FaDu), and normal cell line (HOK) were used to validate the expressions of hub genes. Moreover, additional bioinformatics analyses were performed to further evaluate the mechanisms of hub genes in the development of HNSC. In total, 1372 reliable DEGs were screened from the GSE6631 dataset. Out of these DEGs, only based on the four up-regulated hub genes, including UBE2C (Ubiquitin-conjugating enzyme E2C), BUB1B (BUB1 Mitotic Checkpoint Serine/Threonine Kinase B), MCM4 (Minichromosome Maintenance Complex Component 4), and KIF23 (Kinesin family member 23), we developed and validated a diagnostic and prognostic model for HNSC patients. Moreover, some interesting correlations observed between hub gene expression and infiltration level of immune cells may also improve our understanding of HNSC immunotherapy. In conclusion, we developed a novel diagnostic and prognostic model consisting of the UBE2C, BUB1B, MCM4, and KIF23 genes for HNSC patients. However, the efficiency of this model needs to be verified through more experimental studies.
Indexed as
Identifiers
38058845PMC10695818W4389452630What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.